Showing 2411-2420 of 3329 results for "".
- FDA Approves South Korean Neurotoxin for Frown Lineshttps://modernaesthetics.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week. According to a press release, Hugel Inc. plans to accelerate its transition for approved medical use with
- California Lawmaker Introduces Legislation to Stop Sale of ‘Anti-Aging’ Skincare Products to Childrenhttps://modernaesthetics.com/news/california-lawmaker-introduces-legislation-to-stop-sale-of-anti-aging-skincare-products-to-children/2473742/A California lawmaker aims to protect children from anti-aging products as a result of the “Sephora kids” trend. The “Sephora kids” trend came about with the social media influencer boom, when skincare companies used influencers to market their products; but they also receive unexpected consumers
- AMI Opens Three New US Training Centershttps://modernaesthetics.com/news/ami-opens-three-new-us-training-centers/2473739/Allergan Medical Institute (AMI) will open three new state-of-the-art training centers in the United States, according to an announcement from Allergan Aesthetics, an AbbVie company. AMI says its curriculum is designed to accelerate the science and art of aesthetics and, along with the com
- New Data Reveals GLP-1 Medications Impact on Medical Aesthetics Growthhttps://modernaesthetics.com/news/new-data-reveals-glp-1-medications-impact-on-medical-aesthetics-growth/2473724/Guidepoint Qsight revealed new insights Thursday on the state of the $17.5 billion medical aesthetics industry, which was up 2% in 2024. The findings highlight how the integration of glucagon-like peptide-1 (GLP-1) medications for weight loss is reshaping the aesthetics market. GLP-1 medic
- SkinSpirit Medspa Expands Into Nordstromhttps://modernaesthetics.com/news/skinspirit-medspa-expands-into-nordstrom/2473725/Aesthetic treatments such as neurotoxin injections and dermal fillers will be available at Nordstrom’s flagship location in New York City through SkinSpirit, the medspa announced. SkinSpirit, which has 50 locations around the country, becomes the first medical aesthetics brand to operate w
- AACS to Host Scientific Meeting Feb. 20-22 in Californiahttps://modernaesthetics.com/news/aacs-to-host-scientific-meeting-feb-20-22-in-california/2473720/The American Academy of Cosmetic Surgery (AACS) will conduct its 41st Annual Scientific Meeting (ASM) on February 20-22, 2025, with an optional pre-meeting workshop, “Sculpting Human Figure 101: The Integration of Art and Science,” on February 1
- Survey Finds Muscle Maintenance Gaps Among Medical Weight Loss Usershttps://modernaesthetics.com/news/survey-finds-muscle-maintenance-gaps-among-medical-weight-loss-users/2473714/BTL Aesthetics released insights from a recent survey conducted by NewBeauty uncovering the key challenges faced by medical weight loss patients when it comes to muscle maintenance and facial aesthetics. The survey including nearly 2,000 participants from the United States and hig
- Dr. Patrick J. Byrne Named Next President of AAFPRShttps://modernaesthetics.com/news/dr-patrick-j-byrne-named-next-president-of-aafprs/2473707/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) announced Patrick J. Byrne, MD, MBA, as president for the 2024-2025 term year. Dr. Byrne, an Ohio-based facial plastic and reconstructive surgeon, formally assumed his new role at the 2024 AAFPRS Annual Business Meeting in
- ASDS Abstract Highlights Potential of ALA-PDThttps://modernaesthetics.com/news/asds-abstract-highlights-potential-of-ala-pdt/2473704/Photodynamic therapy (PDT) with aminolevulonic acid (ALA) was the topic of the top 10 abstract “Fine Wrinkles and the Art of Light,” presented by Luke Horton, MD, at the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting. Dr. Horton performed a study along
- Study Backs CP-GEP Tests’ Accuracyhttps://modernaesthetics.com/news/study-backs-cp-gep-tests-accuracy/2473699/Patients with clinically node-negative primary cutaneous melanoma undergoing sentinel lymph node biopsies (SLNBs) who were classified as “high risk” according to CP-GEP tests were approximately three times more likely to be SLN positive, according to data presented October 13 at the S